The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CHME | +1,066.67% | +86.17% | +13.24% | -99% |
| S&P | +13.95% | +78.35% | +12.25% | +395% |
China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. Its products include shuangdan capsules, houerhuan anti-inflammatory capsules, shugan yipi granules, danggui tiaojing granules, huangzao granules, pingfeng shengmai capsules, danqi and naodesheng tablets. The company was founded on February 10, 2005 and is headquartered in Guangzhou, China.
No news articles found for China Medicine.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
